Higlance Laboratories Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 30-11-2024
- Paid Up Capital ₹ 6.00 Cr
as on 30-11-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.86 Cr
as on 30-11-2024
- Revenue -22.41%
(FY 2024)
- Profit -78.08%
(FY 2024)
- Ebitda -70.47%
(FY 2024)
- Net Worth 6.36%
(FY 2024)
- Total Assets -2.41%
(FY 2024)
About Higlance Laboratories
The Corporate was formerly known as Hi Glance Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 6.00 Cr.
The company currently has active open charges totaling ₹1.86 Cr.
The Key Managerial Personnel (KMP) at Higlance Laboratories Private Limited India is Anishrava Agrawal as COMPANY SECRETARY. Ajay Singh, Sanjay Singh, and Kalawati Devi serve as directors at the Company.
- CIN/LLPIN
U24239DL2003PTC120847
- Company No.
120847
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Higlance Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Singh  | Managing Director | 11-Jun-2003 | Current |
| Anishrava Agrawal | Company Secretary | 30-Sep-2011 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajay Singh | Whole-Time Director | 11-Jun-2003 | Current |
| Kalawati Devi | Director | 11-Jun-2003 | Current |
Financial Performance of Higlance Laboratories.
Higlance Laboratories Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 22.41% decrease. The company also saw a substantial fall in profitability, with a 78.08% decrease in profit. The company's net worth moved up by a moderate rise of 6.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Higlance Laboratories?
In 2024, Higlance Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 19 Oct 2006 | ₹1.86 Cr | Open |
How Many Employees Work at Higlance Laboratories?
Higlance Laboratories has a workforce of 357 employees as of Nov 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Higlance Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Higlance Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
